143 related articles for article (PubMed ID: 37990864)
21. "
Sánchez-Velázquez P; Moosmann N; Töpel I; Piso P
World J Gastroenterol; 2016 Dec; 22(46):10249-10253. PubMed ID: 28028374
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Riss S; Mohamed F; Dayal S; Cecil T; Stift A; Bachleitner-Hofmann T; Moran B
Eur J Surg Oncol; 2013 Sep; 39(9):931-7. PubMed ID: 23810280
[TBL] [Abstract][Full Text] [Related]
23. Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial.
Glockzin G; Zeman F; Croner RS; Königsrainer A; Pelz J; Ströhlein MA; Rau B; Arnold D; Koller M; Schlitt HJ; Piso P
Clin Colorectal Cancer; 2018 Dec; 17(4):285-296. PubMed ID: 30131226
[TBL] [Abstract][Full Text] [Related]
24. A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
Lee RM; Gamboa AC; Turgeon MK; Zaidi MY; Kimbrough C; Leiting J; Grotz T; Lee AJ; Fournier K; Powers B; Dineen S; Baumgartner JM; Veerapong J; Mogal H; Clarke C; Wilson G; Patel S; Hendrix R; Lambert L; Pokrzywa C; Abbott DE; LaRocca CJ; Raoof M; Greer J; Johnston FM; Staley CA; Cloyd JM; Maithel SK; Russell MC
J Surg Oncol; 2021 Jan; 123(1):187-195. PubMed ID: 33002202
[TBL] [Abstract][Full Text] [Related]
25. Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?
Baratti D; Kusamura S; Iusco D; Cotsoglou C; Guaglio M; Battaglia L; Virzì S; Mazzaferro V; Deraco M
Dis Colon Rectum; 2018 Sep; 61(9):1026-1034. PubMed ID: 30086051
[TBL] [Abstract][Full Text] [Related]
26. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.
Chow FC; Yip J; Foo DC; Wei R; Choi HK; Ng KK; Lo OS
Asian J Surg; 2021 Jan; 44(1):221-228. PubMed ID: 32605790
[TBL] [Abstract][Full Text] [Related]
27. Pelvic exenteration combined with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced primary or recurrent colorectal cancer with peritoneal metastases.
Brown KGM; Ansari N; Solomon MJ; Austin KKS; Hamilton AER; Young CJ
Colorectal Dis; 2021 Jan; 23(1):186-191. PubMed ID: 32978813
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
29. Colorectal peritoneal metastases: Optimal management review.
Sánchez-Hidalgo JM; Rodríguez-Ortiz L; Arjona-Sánchez Á; Rufián-Peña S; Casado-Adam Á; Cosano-Álvarez A; Briceño-Delgado J
World J Gastroenterol; 2019 Jul; 25(27):3484-3502. PubMed ID: 31367152
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of combined resection of colorectal peritoneal and liver metastases.
Downs-Canner S; Shuai Y; Ramalingam L; Pingpank JF; Holtzman MP; Zeh HJ; Bartlett DL; Choudry HA
J Surg Res; 2017 Nov; 219():194-201. PubMed ID: 29078882
[TBL] [Abstract][Full Text] [Related]
31. Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy.
Sutton PA; O'Dwyer ST; Barriuso J; Aziz O; Selvasekar CR; Renehan AG; Wilson MS
Surg Oncol; 2021 Sep; 38():101572. PubMed ID: 33915487
[TBL] [Abstract][Full Text] [Related]
32. Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience.
Navez J; Remue C; Leonard D; Bachmann R; Kartheuser A; Hubert C; Coubeau L; Komuta M; Van den Eynde M; Zech F; Jabbour N
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):666-673. PubMed ID: 27646023
[TBL] [Abstract][Full Text] [Related]
33. Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Hentzen JEKR; van der Plas WY; Constansia RDN; Been LB; Hoogwater FJH; van Ginkel RJ; van Dam GM; Hemmer PHJ; Kruijff S
BJS Open; 2019 Dec; 3(6):812-821. PubMed ID: 31832588
[TBL] [Abstract][Full Text] [Related]
34. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes.
Rosa F; Galiandro F; Ricci R; Di Miceli D; Quero G; Fiorillo C; Cina C; Alfieri S
Langenbecks Arch Surg; 2021 Dec; 406(8):2797-2805. PubMed ID: 34661754
[TBL] [Abstract][Full Text] [Related]
35. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection for concurrent peritoneal and hepatic metastases of gastrointestinal and gynecological primary tumors.
Horvath P; Beckert S; Königsrainer A; Nadalin S; Königsrainer I
J Visc Surg; 2019 Dec; 156(6):475-484. PubMed ID: 31324533
[TBL] [Abstract][Full Text] [Related]
36. Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin.
Adileh M; Yuval JB; Walch HS; Chatila WK; Yaeger R; Garcia-Aguilar J; Schultz N; Paty PB; Cercek A; Nash GM
Ann Surg Oncol; 2021 Feb; 28(2):1109-1117. PubMed ID: 32844293
[TBL] [Abstract][Full Text] [Related]
37. Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Blackham AU; Russell GB; Stewart JH; Votanopoulos K; Levine EA; Shen P
Ann Surg Oncol; 2014 Aug; 21(8):2667-74. PubMed ID: 24615177
[TBL] [Abstract][Full Text] [Related]
38. ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Tonello M; Sommariva A
Ann Surg Oncol; 2022 Jun; 29(6):3418-3419. PubMed ID: 34743279
[No Abstract] [Full Text] [Related]
39. [Treatment of peritoneal metastases from colorectal cancer].
Nielsen JC; Verwaal VJ
Ugeskr Laeger; 2022 Aug; 184(31):. PubMed ID: 35959828
[TBL] [Abstract][Full Text] [Related]
40. A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature.
Ramírez-Plaza CP; Moreno-Ruiz FJ; Pérez-Daga JA
World J Surg Oncol; 2015 Aug; 13():233. PubMed ID: 26231227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
